Lal PathLabs Q4 Results: Net profit rises 49%, announces dividend of ₹6 per share

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Dr Lal PathLabs revealed its financial performance for the fourth quarter of the previous fiscal year. The diagnostic chain company posted 49% rise in net profit for the fourth quarter, reaching ₹84.5 crore compared to ₹56.7 crore in the same period last year.

The company also announced a dividend of ₹6 per equity share. “Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2024 subject to approval of the Shareholders at ensuing Annual General Meeting (“AGM”) of the Company. The record date for the purpose of payment of final dividend shall be June 10, 2024.”

The company’s revenue witnessed an 11% rise, reaching ₹545.5 crore as compared to ₹491 crore in the fourth quarter of FY23. Dr Lal PathLabs also reported improvement in its earnings before interest, taxes, depreciation, and amortisation (EBITDA), which rose by 25.2% to ₹144.7 crore, up from ₹115.6 crore in the corresponding quarter of the previous year.

The margin performance also exhibited a positive trend, with the margin standing at 26.5% compared to 23.5% in the same period last year.

Also Read: Indian Overseas Bank targets 3.25%-3.30% net interest margin in FY25

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow